SynthesisFrontiers in oncology2021

An Indirect Comparison Between Nivolumab + Ipilimumab + Two Cycles of Chemotherapy vs. Pembrolizumab + Chemotherapy as First-Line Treatment for Metastatic Non-Small Cell Lung Cancer.

Panpan Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.